drugset / Trial / NCT02652156

TAP Block for Postoperative Pain Control

NCT02652156

Phase 3 Terminated 14 enrolled Joshua Herskovic
RandomizedParallel-groupOpen-labelTreatment

Summary

This clinical trial will examine differences in the effectiveness between three (3) commonly used methods and/or medications used to perform a transversus abdominis plane (TAP) block for post-operative pain control. The transversus abdominis muscle is either side between the lowest rib and the hip bone. Group A subjects will undergo post-operative pain relief treatment with a single injection of Bupivacaine injected into the TAP. Group B subjects will undergo post-operative pain relief treatment with a single injection of Exparel®, a liposomal form of bupivacaine into the TAP. Group C subjects will be treated with a continuous infusion of the local anesthetic ropivacaine with the ON-Q® pump. There will be no placebo group in this study.

Timeline

Start
2015-11-01
Primary completion
2016-04-16
Completion
2016-04-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 25 ml Other
Comparator Bupivacaine Other / unclassified 30 ml Other
Comparator Bupivacaine Other / unclassified 133 mg Other
Comparator Ropivacaine Other / unclassified 7 ml

Indications